Work

Evaluation of surufatinib, an orally available VEGFR, FGFR1 and CSF-1R inhibitor, in combination with immune checkpoint blockade or chemotherapy in preclinical tumor models

Year: 2020

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(20)31132-1

Authors: M. Cheng, S. Fan, R. Tang, W. Zhang, J. Hu, J. Yu, D. Shi, C. Wang, L. Wang, W. Qing, Y. Ren, W. Su

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3097744604

FWCI: 0.071

Cites:

Cited by: 5

Related to: 10